329 related articles for article (PubMed ID: 15542810)
41. Mutational analysis of beta-catenin and the RAS-RAF signalling pathway in early flat-type colorectal tumours.
Mikami M; Nosho K; Yamamoto H; Takahashi T; Maehata T; Taniguchi H; Adachi Y; Imamura A; Fujita M; Hosokawa M; Itoh F; Imai K; Shinomura Y
Eur J Cancer; 2006 Nov; 42(17):3065-72. PubMed ID: 17011185
[TBL] [Abstract][Full Text] [Related]
42. BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiency.
Oliveira C; Pinto M; Duval A; Brennetot C; Domingo E; Espín E; Armengol M; Yamamoto H; Hamelin R; Seruca R; Schwartz S
Oncogene; 2003 Dec; 22(57):9192-6. PubMed ID: 14668801
[TBL] [Abstract][Full Text] [Related]
43. Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer.
Artale S; Sartore-Bianchi A; Veronese SM; Gambi V; Sarnataro CS; Gambacorta M; Lauricella C; Siena S
J Clin Oncol; 2008 Sep; 26(25):4217-9. PubMed ID: 18757341
[No Abstract] [Full Text] [Related]
44. MGMT promoter methylation and field defect in sporadic colorectal cancer.
Shen L; Kondo Y; Rosner GL; Xiao L; Hernandez NS; Vilaythong J; Houlihan PS; Krouse RS; Prasad AR; Einspahr JG; Buckmeier J; Alberts DS; Hamilton SR; Issa JP
J Natl Cancer Inst; 2005 Sep; 97(18):1330-8. PubMed ID: 16174854
[TBL] [Abstract][Full Text] [Related]
45. Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer.
Miranda E; Destro A; Malesci A; Balladore E; Bianchi P; Baryshnikova E; Franchi G; Morenghi E; Laghi L; Gennari L; Roncalli M
Br J Cancer; 2006 Oct; 95(8):1101-7. PubMed ID: 16969349
[TBL] [Abstract][Full Text] [Related]
46. Hypermethylation of CpG island loci of multiple tumor suppressor genes in retinoblastoma.
Cohen Y; Merhavi-Shoham E; Avraham RB; Frenkel S; Pe'er J; Goldenberg-Cohen N
Exp Eye Res; 2008 Feb; 86(2):201-6. PubMed ID: 18068703
[TBL] [Abstract][Full Text] [Related]
47. Clinicopathological and molecular characterization of deficient mismatch repair colorectal cancer.
Yamada A; Yamamoto Y; Minamiguchi S; Kamada M; Sunami T; Ohashi S; Seno H; Kawada K; Muto M
Hum Pathol; 2022 Dec; 130():1-9. PubMed ID: 36150551
[TBL] [Abstract][Full Text] [Related]
48. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas.
Chan TL; Zhao W; Leung SY; Yuen ST;
Cancer Res; 2003 Aug; 63(16):4878-81. PubMed ID: 12941809
[TBL] [Abstract][Full Text] [Related]
49. B-Raf(V600E) cooperates with alternative spliced Rac1b to sustain colorectal cancer cell survival.
Matos P; Oliveira C; Velho S; Gonçalves V; da Costa LT; Moyer MP; Seruca R; Jordan P
Gastroenterology; 2008 Sep; 135(3):899-906. PubMed ID: 18602919
[TBL] [Abstract][Full Text] [Related]
50. Association of microRNA-31 with BRAF mutation, colorectal cancer survival and serrated pathway.
Nosho K; Igarashi H; Nojima M; Ito M; Maruyama R; Yoshii S; Naito T; Sukawa Y; Mikami M; Sumioka W; Yamamoto E; Kurokawa S; Adachi Y; Takahashi H; Okuda H; Kusumi T; Hosokawa M; Fujita M; Hasegawa T; Okita K; Hirata K; Suzuki H; Yamamoto H; Shinomura Y
Carcinogenesis; 2014 Apr; 35(4):776-83. PubMed ID: 24242331
[TBL] [Abstract][Full Text] [Related]
51. CpG island methylation is frequently present in tubulovillous and villous adenomas and correlates with size, site, and villous component.
Kakar S; Deng G; Cun L; Sahai V; Kim YS
Hum Pathol; 2008 Jan; 39(1):30-6. PubMed ID: 17950780
[TBL] [Abstract][Full Text] [Related]
52. Distinct Clinicopathological Patterns of Mismatch Repair Status in Colorectal Cancer Stratified by KRAS Mutations.
Li W; Zhi W; Zou S; Qiu T; Ling Y; Shan L; Shi S; Ying J
PLoS One; 2015; 10(6):e0128202. PubMed ID: 26042813
[TBL] [Abstract][Full Text] [Related]
53. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.
Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK
Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419
[TBL] [Abstract][Full Text] [Related]
54. Comethylation of p16 and MGMT genes in colorectal carcinoma: correlation with clinicopathological features and prognostic value.
Krtolica K; Krajnovic M; Usaj-Knezevic S; Babic D; Jovanovic D; Dimitrijevic B
World J Gastroenterol; 2007 Feb; 13(8):1187-94. PubMed ID: 17451198
[TBL] [Abstract][Full Text] [Related]
55. Mutational analysis of the BRAF gene in colorectal mucinous carcinoma in association with histological configuration.
Yoshitake N; Fujii S; Mukawa K; Tominaga K; Fukui H; Ichikawa K; Tomita S; Ono Y; Imai Y; Terano A; Hiraishi H; Fujimori T
Oncol Rep; 2007 Jan; 17(1):9-15. PubMed ID: 17143472
[TBL] [Abstract][Full Text] [Related]
56. Aberrant epigenetic inactivation of RASSF1A and MGMT gene and genetic mutations of KRAS, cKIT and BRAF in Indian testicular germ cell tumours.
Ahmad F; Surve P; Natarajan S; Patil A; Pol S; Patole K; Das BR
Cancer Genet; 2020 Feb; 241():42-50. PubMed ID: 31653608
[TBL] [Abstract][Full Text] [Related]
57. Next-generation sequencing reveals heterogeneous genetic alterations in key signaling pathways of mismatch repair deficient colorectal carcinomas.
Wang J; Li R; He Y; Yi Y; Wu H; Liang Z
Mod Pathol; 2020 Dec; 33(12):2591-2601. PubMed ID: 32620917
[TBL] [Abstract][Full Text] [Related]
58. Localization of active, dually phosphorylated extracellular signal-regulated kinase 1 and 2 in colorectal cancer with or without activating BRAF and KRAS mutations.
Holck S; Bonde J; Pedersen H; Petersen AA; Chaube A; Nielsen HJ; Larsson LI
Hum Pathol; 2016 Aug; 54():37-46. PubMed ID: 27036313
[TBL] [Abstract][Full Text] [Related]
59. Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer.
van Engeland M; Weijenberg MP; Roemen GM; Brink M; de Bruïne AP; Goldbohm RA; van den Brandt PA; Baylin SB; de Goeij AF; Herman JG
Cancer Res; 2003 Jun; 63(12):3133-7. PubMed ID: 12810640
[TBL] [Abstract][Full Text] [Related]
60. Clinicopathologic features and prognostic value of KRAS, NRAS and BRAF mutations and DNA mismatch repair status: A single-center retrospective study of 1,834 Chinese patients with Stage I-IV colorectal cancer.
Guo TA; Wu YC; Tan C; Jin YT; Sheng WQ; Cai SJ; Liu FQ; Xu Y
Int J Cancer; 2019 Sep; 145(6):1625-1634. PubMed ID: 31162857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
